FDA guidelines to help personalized drug development

As part of an agency-wide initiative to speed development of new medical products through the science of pharmacogenomics, the FDA has issued a final guidance regarding pharmacogenomic data submissions.


Leave a Reply

Your email address will not be published. Required fields are marked *

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Subscribe!